Novartis team perseveres to develop more personalized approach to breast cancer therapy.

Novartis is investing in a novel type of medicine to reduce the risk of heart disease.

Novartis investigators find genetic explanations for why some young patients relapse.

Combination of two compounds shows promise in the lab

Novartis data scientists are using super-resolution microscopy to see neurodegeneration the moment it starts.

In Wendi Yajnik’s quest to find new technologies that could transform medicine, relationships are priority No. 1.

Novartis researchers are peering deep inside knees to see if regenerated cartilage is springy like natural cartilage.